Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
Driven by a surging pipeline, the MASH therapeutic landscape is radically transforming as more drugs reach clinical trials. While Madrigal's Rezdiffra marked a groundbreaking first approval, it also ...
These lightly cheesy, super-smooth herbed mashed potatoes are a great Thanksgiving upgrade. Grace Parisi a former senior test kitchen editor for Food & Wine, where she wrote several successful monthly ...
MASH, which was previously known as non–alcohol related steatohepatitis (NASH), is often asymptomatic or leads to nonspecific symptoms, making progression to more severe stages of liver disease ...
Unjumble Michigan politics with MichMash. Each week, Cheyna Roth, Zach Gorchow and Alethia Kasben interview lawmakers and politicos, and unpack the statewide issues that affect you. MichMash is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback